Resources · GMP documentation
Writing on GMP batch documentation for QA teams at small and mid-size manufacturers, by Kinjal Patel — twelve years in pharmaceutical quality assurance. Every piece is written from the regulation it cites, not from a summary of it. Nothing sits behind a form.
Articles
Artificial intelligence in pharmaceuticals is a $1.94 billion market headed toward $16.49 billion by 2034 (Precedence Research, 2025), yet most explanations still start with robots or end with drug discovery
AI is software that finds patterns in data and uses them to suggest, predict or check things — no robots required. Explained through three examples from a normal production day.
Everything here is readable in full without an email address. There is no signup form on this page and there will not be one.
Byline
Every regulatory statement on this site is signed off by her before it goes live.
“I have written the documents these pages describe, and I have defended them in an inspection. That is the only qualification these pages claim.”
Kinjal Patel · Co-founder, PharmaSynapse
Early access
We are letting a small number of manufacturers in early. You send one approved master formula and your current record format. We draft it, then walk the output line by line — Kinjal on the record, Mitesh on the system.
There is no pilot yet and no deployment data.